SCHEMBL2811020

SCHEMBL2811020

COc1ccc(CN2CCc3nn(Cc4ccccc4)c4nc(NCCc5cccc(OC)c5OC)nc2c34)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 1/20 0.40
BCHE P06276 3/20 0.37
ACHE P22303 2/20 0.37
BACE1 P56817 2/20 0.37
CLPP Q16740 1/20 0.36
ABCB1 P08183 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
POLB P06746 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HTT P42858 1/20 0.35
HSD17B10 Q99714 1/20 0.35
OPRK1 P41145 2/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPT P10636 1/20 0.34
TLR7 Q9NYK1 1/20 0.34
PARP1 P09874 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2812029 0.90 PDE5A (0.40) PDE5ABCHEACHEBACE1ABCB1
SCHEMBL2814449 0.89 ADORA3 (0.42) CLPPALDH1A1MAPTADORA3ADORA2A
SCHEMBL2816708 0.86 ACP1 (0.41) CLPPABCB1POLBALDH1A1HTT
SCHEMBL2810351 0.86 OPRK1 (0.41) BCHEACHECLPPHTTOPRK1
SCHEMBL2812906 0.86 CLPP (0.40) BCHEACHECLPPHTTOPRK1
SCHEMBL2812217 0.86 ADORA3 (0.44) CLPPPOLBALDH1A1HTTHSD17B10
SCHEMBL2808269 0.84 CLPP (0.48) ACHEBACE1CLPPPOLBALDH1A1
SCHEMBL2809628 0.83 CLPP (0.38) CLPPHTTOPRK1MEN1KMT2A
SCHEMBL2813947 0.83 ACP1 (0.38) CLPPALDH1A1MEN1KMT2AMAPT
SCHEMBL2812153 0.83 CCNE2 (0.49) MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 PDE5A 1006/4885BCHE 4134/4885ACHE 4402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.